Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Which index funds deliver the best after-tax returns in 2024 retirement scenarios by balancing tax efficiency, tracking accuracy, and costs.
28,168 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
As markets wobble, investors turn to stalwarts with decades of dividend increases. Three dividend kings that have rai...
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...
XRP/BTC is flashing a major warning as the pair struggles under key moving averages and tests vital support, keeping ...
BNB rose on March 24, 2026, as volume surged and traders weigh whether it can reach the monthly target, boosted by st...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
Tech-driven gains keep the Nasdaq Composite in play as AI optimism fuels trading. This update tracks live nasdaq comp...
South Korea’s KOSPI dropped sharply after circuit-breaker rules kicked in, fueling anxiety about a potential spillove...
If you’re building a better payments stock long thesis, American Express and Visa offer different routes to durable c...
This guide unpacks Granite Ridge earnings in plain terms. Learn the key metrics, what to listen for in the GRNT earni...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
A high-profile court bill can feel overwhelming, but it’s also a chance to sharpen your money habits. This article br...